MediQuest Therapeutics Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Out of Business

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

MediQuest Therapeutics General Information

Description

Developer of bio-pharmaceutical products designed to provide treatment of inflammatory and infectious diseases. The company's new drug application like NDA and topical amphiMatrix TAM drug delivery technology is designed to transport agents through thickened, diseased skin and nails, enabling patients to minimize local irritation and systemic side effects as compared to other topical delivery technologies.

Contact Information

Website
www.mqti.com
Formerly Known As
Origen Corporation, Oridigm Corporation
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 300 East Pine Street
  • Seattle, WA 98122
  • United States
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Therapeutic Devices
Vertical(s)
Corporate Office
  • 300 East Pine Street
  • Seattle, WA 98122
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MediQuest Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 28-Apr-2014 Completed Out of Business
6. Later Stage VC (Series B) 29-May-2009 Completed Generating Revenue
5. Later Stage VC 12-Nov-2007 Completed Generating Revenue
4. Early Stage VC (Series A) 15-Jun-2006 Completed Startup
3. Early Stage VC (Series B) 28-Oct-2004 Completed Startup
2. Angel (individual) 03-Sep-2003 $100K $100K Completed Startup
1. Grant 02-Jun-2003 $1.12M Completed Startup
To view MediQuest Therapeutics’s complete valuation and funding history, request access »

MediQuest Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A1
Series A 47,000,000 $0.000500 $0.04 $0.6 $0.9 1x $0.6 24.31%
To view MediQuest Therapeutics’s complete cap table history, request access »

MediQuest Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bio-pharmaceutical products designed to provide treatment of inflammatory and infectious diseases. The comp
Drug Discovery
Seattle, WA
13 As of 2017

Bresso, Italy
 

Bedford, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MediQuest Therapeutics Competitors (17)

One of MediQuest Therapeutics’s 17 competitors is The Zambon Group, a Private Debt Financed company based in Bresso, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
The Zambon Group Private Debt Financed Bresso, Italy
Ocular Therapeutix Formerly VC-backed Bedford, MA
EyePoint Corporation Watertown, MA
PulseSight Therapeutics Venture Capital-Backed Paris, France
Minoryx Venture Capital-Backed Barcelona, Spain
You’re viewing 5 of 17 competitors. Get the full list »

MediQuest Therapeutics Patents

MediQuest Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202409447-D0 Life in a can Inactive 30-Jun-2024
AU-2009209124-A1 Improving the appearance of nails Inactive 30-Jan-2008
CA-2713496-A1 Improving the appearance of nails Inactive 30-Jan-2008
EP-2234582-A2 Improving the appearance of nails Inactive 30-Jan-2008
WO-2009097471-A2 Improving the appearance of nails Inactive 30-Jan-2008 A61K8/37
To view MediQuest Therapeutics’s complete patent history, request access »

MediQuest Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MediQuest Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute for Allergy and Infectious Disease Government
To view MediQuest Therapeutics’s complete investors history, request access »

MediQuest Therapeutics FAQs

  • When was MediQuest Therapeutics founded?

    MediQuest Therapeutics was founded in 2002.

  • Where is MediQuest Therapeutics headquartered?

    MediQuest Therapeutics is headquartered in Seattle, WA.

  • What is the size of MediQuest Therapeutics?

    MediQuest Therapeutics has 13 total employees.

  • What industry is MediQuest Therapeutics in?

    MediQuest Therapeutics’s primary industry is Drug Discovery.

  • Is MediQuest Therapeutics a private or public company?

    MediQuest Therapeutics is a Private company.

  • What is MediQuest Therapeutics’s current revenue?

    The current revenue for MediQuest Therapeutics is .

  • How much funding has MediQuest Therapeutics raised over time?

    MediQuest Therapeutics has raised $50.5M.

  • Who are MediQuest Therapeutics’s investors?

    National Institute for Allergy and Infectious Disease has invested in MediQuest Therapeutics.

  • Who are MediQuest Therapeutics’s competitors?

    The Zambon Group, Ocular Therapeutix, EyePoint, PulseSight Therapeutics, and Minoryx are some of the 17 competitors of MediQuest Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process